z-logo
Premium
Hepatocytes from α 1B ‐adrenoceptor knockout mice reveal compensatory adrenoceptor subtype substitution
Author(s) -
Deighan Clare,
Woollhead Alison M,
Colston Janet F,
McGrath John C
Publication year - 2004
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0705872
Subject(s) - prazosin , radioligand , antagonist , chemistry , medicine , endocrinology , population , radioligand assay , ligand (biochemistry) , biology , binding site , microbiology and biotechnology , receptor , biochemistry , environmental health
α 1 ‐Adrenoceptors (ARs) play an important functional role in the liver; yet little is known about their cellular location. We identified the subtypes present in wild‐type (WT) and α 1B ‐AR knockout (KO) mice livers at 3 and 4 months of age, and investigated their distribution in hepatocytes. The fluorescent α 1 ‐AR antagonist quinazolinyl piperazine borate‐dipyrromethene (QAPB) was used to visualise hepatic α 1 ‐ARs and radioligand binding with [ 3 H]‐prazosin was used to quantify the α 1 ‐AR population. QAPB and [ 3 H]‐prazosin bound specifically to hepatic α 1 ‐ARs with nanomolar affinity. The cellular distribution of α 1 ‐ARs was similar in WT and α 1B ‐AR KO hepatocytes; QAPB binding was distributed diffusely throughout the cell with no binding evident on the plasma membrane. Radioligand binding produced B max values as follows: 3‐month WT – 76±3.3 fmol mg −1 ; 4‐month WT – 50±3.1 fmol mg −1 ; 3‐month α 1B ‐AR KO – 7.4±0.73 fmol mg −1 ; 4‐month α 1B ‐AR KO – 30±2.0 fmol mg −1 . In 3‐ and 4‐month WT liver, all antagonists acted competitively. RS100329 ( α 1A ‐selective) and BMY7378 ( α 1D ‐selective) bound with low affinities, indicating the presence of α 1B ‐ARs. In 4‐month α 1B ‐AR KO liver prazosin produced a biphasic curve, whereas RS100329 and BMY7378 produced monophasic curves of high and low affinity, respectively, indicating the presence of α 1A ‐ARs. In conclusion, we have made the novel observation that α 1 ‐ARs can compensate for one another in the absence of the endogenously expressed receptor; yet there appears to be no subtype‐specific subcellular location of α 1 ‐ARs; the WT livers express α 1B ‐ARs, while α 1B ‐AR KO livers express α 1A ‐ARs. This study provides new insights into both hepatocyte and α 1 ‐AR biology.British Journal of Pharmacology (2004) 142 , 1031–1037. doi: 10.1038/sj.bjp.0705872

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom